Literature DB >> 11884422

Cutting edge: CD83 regulates the development of cellular immunity.

Nathalie Scholler1, Martha Hayden-Ledbetter, Amber Dahlin, Ingegerd Hellström, Karl Erik Hellström, Jeffrey A Ledbetter.   

Abstract

We recently found that human CD83, a marker of mature dendritic cells, is an adhesion receptor that binds to resting monocytes and a subset of activated CD8(+) T cells. We injected CD83-Ig into mice transplanted with the immunogenic P815 mastocytoma and showed that it significantly enhanced the rate of tumor growth and inhibited the development of cytotoxic T cells. In contrast, mice immunized with CD83-transfected K1735 cells, a poorly immunogenic melanoma, could prevent the outgrowth of wild-type K1735 cells. Studies performed in vitro with human PBL showed that coimmobilized CD83-Ig and anti-CD3 enhanced T cell proliferation and increased the proportion of CD8(+) T cells. CD83-transfected B-lymphoblastoid T51 cells stimulated T cell proliferation more effectively than untransfected T51 cells in MLR cultures and increased the generation of cytolytic T cells. We conclude that CD83 is a functionally important receptor that can regulate the development of cellular immunity by interacting with its ligand(s).

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11884422     DOI: 10.4049/jimmunol.168.6.2599

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  24 in total

1.  Composition and surface charge of DNA-loaded microparticles determine maturation and cytokine secretion in human dendritic cells.

Authors:  Samantha Jilek; Michael Ulrich; Hans P Merkle; Elke Walter
Journal:  Pharm Res       Date:  2004-07       Impact factor: 4.200

2.  CD83 is preformed inside monocytes, macrophages and dendritic cells, but it is only stably expressed on activated dendritic cells.

Authors:  Weiping Cao; Szu Hee Lee; Jinhua Lu
Journal:  Biochem J       Date:  2005-01-01       Impact factor: 3.857

Review 3.  Dendritic cell CD83: a therapeutic target or innocent bystander?

Authors:  Charlene M Prazma; Thomas F Tedder
Journal:  Immunol Lett       Date:  2007-10-29       Impact factor: 3.685

4.  Th-1 polarization is regulated by dendritic-cell comparison of MHC class I and class II antigens.

Authors:  William K Decker; Dongxia Xing; Sufang Li; Simon N Robinson; Hong Yang; David Steiner; Krishna V Komanduri; Elizabeth J Shpall
Journal:  Blood       Date:  2009-01-26       Impact factor: 22.113

5.  Priming CD8+ T cells with dendritic cells matured using TLR4 and TLR7/8 ligands together enhances generation of CD8+ T cells retaining CD28.

Authors:  Jeffrey S Pufnock; Melinda Cigal; Lisa S Rolczynski; Erica Andersen-Nissen; Mathias Wolfl; M Juliana McElrath; Philip D Greenberg
Journal:  Blood       Date:  2011-04-14       Impact factor: 22.113

6.  Multiple interferon regulatory factor and NF-κB sites cooperate in mediating cell-type- and maturation-specific activation of the human CD83 promoter in dendritic cells.

Authors:  Marcello F Stein; Stefan Lang; Thomas H Winkler; Andrea Deinzer; Sebastian Erber; Dirk M Nettelbeck; Elisabeth Naschberger; Ramona Jochmann; Michael Stürzl; Robert K Slany; Thomas Werner; Alexander Steinkasserer; Ilka Knippertz
Journal:  Mol Cell Biol       Date:  2013-01-22       Impact factor: 4.272

7.  Expression of CD83 in the murine immune system.

Authors:  Matthias Wolenski; Sven O Cramer; Svenja Ehrlich; Christiane Steeg; Gudrun Grossschupff; Klara Tenner-Racz; Paul Racz; Bernhard Fleischer; Arne von Bonin
Journal:  Med Microbiol Immunol       Date:  2003-04-10       Impact factor: 3.402

8.  Activation of cord blood myeloid dendritic cells by Trypanosoma cruzi and parasite-specific antibodies, proliferation of CD8+ T cells, and production of IFN-γ.

Authors:  Patricia Rodriguez; Yves Carlier; Carine Truyens
Journal:  Med Microbiol Immunol       Date:  2011-10-29       Impact factor: 3.402

9.  CD83 polymorphisms and cervical cancer risk.

Authors:  Kelly J Yu; Janet S Rader; Ingrid Borecki; Zhengyan Zhang; Allan Hildesheim
Journal:  Gynecol Oncol       Date:  2009-05-15       Impact factor: 5.482

10.  The CD83 reporter mouse elucidates the activity of the CD83 promoter in B, T, and dendritic cell populations in vivo.

Authors:  Matthias Lechmann; Naomi Shuman; Andrew Wakeham; Tak W Mak
Journal:  Proc Natl Acad Sci U S A       Date:  2008-08-13       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.